- Home
- CRML vs PAHC Comparison
CRML vs PAHC Comparison
Compare CRML & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRML
- PAHC
- Stock Information
- Founded
- CRML N/A
- PAHC 1946
- Country
- CRML United States
- PAHC United States
- Employees
- CRML N/A
- PAHC N/A
- Industry
- CRML
- PAHC Biotechnology: Pharmaceutical Preparations
- Sector
- CRML
- PAHC Health Care
- Exchange
- CRML NYSE
- PAHC Nasdaq
- Market Cap
- CRML 634.1M
- PAHC 682.5M
- IPO Year
- CRML N/A
- PAHC 2014
- Fundamental
- Price
- CRML $6.74
- PAHC $22.28
- Analyst Decision
- CRML
- PAHC Sell
- Analyst Count
- CRML 0
- PAHC 4
- Target Price
- CRML N/A
- PAHC $20.50
- AVG Volume (30 Days)
- CRML 20.7K
- PAHC 145.8K
- Earning Date
- CRML 02-01-2025
- PAHC 02-05-2025
- Dividend Yield
- CRML N/A
- PAHC 2.15%
- EPS Growth
- CRML N/A
- PAHC N/A
- EPS
- CRML N/A
- PAHC 0.43
- Revenue
- CRML $117,660.00
- PAHC $1,046,762,000.00
- Revenue This Year
- CRML N/A
- PAHC $27.25
- Revenue Next Year
- CRML N/A
- PAHC $14.13
- P/E Ratio
- CRML N/A
- PAHC $51.99
- Revenue Growth
- CRML 5.79
- PAHC 7.17
- 52 Week Low
- CRML $5.32
- PAHC $10.04
- 52 Week High
- CRML $22.50
- PAHC $25.98
- Technical
- Relative Strength Index (RSI)
- CRML 47.79
- PAHC 39.62
- Support Level
- CRML $6.25
- PAHC $22.02
- Resistance Level
- CRML $6.86
- PAHC $24.42
- Average True Range (ATR)
- CRML 0.75
- PAHC 0.72
- MACD
- CRML -0.08
- PAHC -0.15
- Stochastic Oscillator
- CRML 19.68
- PAHC 12.92
About CRML CRITICAL METALS CORPORATION
Critical Metals Corp is engaged in lithium exploration in Austria. It is focused on the development of its wholly-owned Wolfsberg Lithium Project (the Wolfsberg Project) located in Carinthia, Austria.
About PAHC Phibro Animal Health Corporation
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.